7 April 2021
At the meeting of 10 March 2021 the RMA:
Determined Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
ankylosing spondylitis | 39/2021 | 40/2021 |
malignant neoplasm of the kidney | 41/2021 | 42/2021 |
seborrhoeic dermatitis | 43/2021 | 44/2021 |
Note: The investigation concerning 'adenocarcinoma of the kidney' has resulted in the determination of Statements of Principles concerning malignant neoplasm of the kidney.
Determined New Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
posterior tibialis tendinopathy | 45/2021 | 46/2021 |
The above SOPs take effect from 27 April 2021.
Summary of Changes
Decided to Undertake Consultation regarding:
Condition | Reasons for Decision | Date for Final Decision |
---|---|---|
solar keratosis | Intention to remove one or more factors | June 2021 |
Completed Investigations
The above determinations conclude the previously advertised investigations into:
New Investigation
Decided to advertise the following investigation:
- diabetes mellitus (focussed review - immune checkpoint inhibitors and interferon)
The above investigation notice appears in the Government Notices Gazette of 6 April 2021.